BiotechTube
Home/Atara Biotherapeutics/Yanina Grant-Huerta
YG

Yanina Grant-Huerta

Chief Accounting Officer

Atara Biotherapeutics

Therapeutic Areas

OncologyAutoimmune Diseases

Atara Biotherapeutics Pipeline

DrugIndicationPhase
EBVALLO™ (tabelecleucel)EBV+ Post-Transplant Lymphoproliferative Disease (PTLD)Approved
ATA3219B-Cell Non-Hodgkin Lymphoma (NHL)Phase 1

Leadership Team at Atara Biotherapeutics

CN
Cokey Nguyen, Ph.D.
President and Chief Executive Officer
View full Atara Biotherapeutics profile